Target intelligence / Profile preview

Progerin

Molecular classification
Structural Protein, Nuclear Protein, Mutant Protein
01

Overview

Progerin is a mutant, truncated form of the nuclear structural protein lamin A, arising from a specific mutation in the LMNA gene. It is most notably implicated in Hutchinson–Gilford progeria syndrome (HGPS), a rare genetic disorder characterized by features of accelerated aging. Progerin also accumulates at lower levels during normal physiological aging and influences nuclear structure, DNA repair, chromatin organization, cellular senescence, and oxidative stress.

02

Mechanism of action

Farnesyltransferase inhibition

03

Biological functions

Nuclear StructureDNA Repair (Impaired)Chromatin Organization (Altered)Cellular Senescence (Promotion)Oxidative Stress (Increased)
04

Disease associations

Hutchinson–Gilford Progeria Syndrome (HGPS)AgingCancer (Context Dependent)
05

Safety considerations

Potential off-target effects of drugs targeting progerinComplex interactions with other cellular pathwaysTissue-specific effects need consideration
06

Interacting drugs

Lonafarnib
07

Biomarkers

Plasma progerin levels

Beyond the preview

Go deeper on Progerin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Progerin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call